Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) released its quarterly earnings results on Friday. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01), Zacks reports. The company had revenue of $3.61 billion for the quarter, compared to the consensus estimate of $3.32 billion. Daiichi Sankyo had a net margin of 12.32% and a return on equity of 15.75%. Daiichi Sankyo updated its FY 2026 guidance to 0.870-0.870 EPS.
Daiichi Sankyo Stock Down 11.5%
OTCMKTS:DSNKY opened at $16.14 on Friday. The company has a quick ratio of 1.64, a current ratio of 2.42 and a debt-to-equity ratio of 0.18. Daiichi Sankyo has a 12-month low of $14.98 and a 12-month high of $27.50. The stock’s fifty day simple moving average is $16.51 and its 200-day simple moving average is $17.73. The firm has a market capitalization of $30.07 billion, a P/E ratio of 17.17, a P/E/G ratio of 3.19 and a beta of -0.17.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on DSNKY. Jefferies Financial Group downgraded Daiichi Sankyo from a “buy” rating to a “hold” rating in a report on Thursday. Zacks Research upgraded Daiichi Sankyo from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 5th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Daiichi Sankyo has an average rating of “Hold”.
Daiichi Sankyo Company Profile
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
See Also
- Five stocks we like better than Daiichi Sankyo
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
- MarketBeat Week in Review – 07/27- 07/31
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
